Aetna supports mHealth diabetes initiative in India

NewsGuard 100/100 Score

Aetna (NYSE: AET), a leading global diversified health care benefits company, announced that it is participating in a diabetes prevention program in India led by non-profit Arogya World that strives to reach one million consumers via mobile text messages. This mobile health (mHealth) initiative, which is being supported by a consortium of organisations, aims to raise awareness about diabetes and its prevention through text messages in 12 languages over two years.

"Diabetes is on the rise around the world, including India where one report estimates that some 40 million Indians are already diabetic. That number is expected to reach 73.5 million by 2025," said Sandip Patel, head of Aetna International. "We want to help people around the world live healthier lives. Prevention is the most important way to fight non-communicable diseases like diabetes, which have a high cost on chronically ill people and society in general. We must both promote wellness and prevention through lifestyle and quality medical care to detect illness before serious medical intervention is required. Aetna's experience has demonstrated that cost associated with early detection and disease management is far outweighed by the cost of acute, often emergency, inpatient hospital treatment.

"We believe this mHealth program will be instrumental in bringing about sustainable social change," added Patel. "Aetna is proud to support this innovative program, and to lend our expertise in analyzing health data and managing diabetes risk."

Aetna is supporting the program in three ways by making a financial contribution to fund the effort; serving on the consortium's advisory committee; and providing health care experience. Aetna will provide insights into disease management, wellness and data analytics techniques based upon its deep experience and successes in these areas.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The role of yogurt in diabetes and obesity prevention